Professor of the effectiveness of Rebamipide enema in treating left-sided ischemic colitis with ulcerAfter Reeders et al ischemic colitis involves the left colon in 75 percent of cases and the right colon in 8 percent. Indicated during surgery for the treatment of type gangrenous ischemic colitis, many patients improve with transient nature of the disease or stenosis with bowel rest by fasting and parenteral administration fluid alone. However, healing is often delayed in patients with ulcerative lesions. Recently , the efficacy of rebamipide enema for the treatment of ulcerative colitis has been reported in Japan.
It provides a forum for both clinicians and scientists. WJG has been indexed and abstracted in Current Contents / Clinical Medicine, Science Citation Index Expanded and Journal Citation Reports / Science Edition, Index Medicus, MEDLINE and PubMed, Chemical Abstracts, EMBASE / Excerpta Medica, Abstracts Journals, Nature Clinical Practice Gastroenterology and Hepatology, CAB Abstracts and Global Health. ISI JCR 2003-2000 IF: 3.445, and 0, a weekly magazine published by WJG Press WJG is published.'Our reports provide fact-based news research and discoveries from around the world. Copyright 2012, NewsRx LLCpublished with a News Reporter Staff News Editor at Cancer Weekly Current study results on rectal cancer was. S-1 reported of Tokushima, carried NewsRx writers, said Research, 'S-1 -based radiochemotherapy is the recommended treatment of rectal carcinoma;. However, the ideal planning and doses are not yet established A phase I study was performed determining the maximum tolerated dose '.. Our News journalists report that additional information, contact S. Morimoto, Tokushima Univ Hosp, Surgery and Transplant, Tokushima 7th Japan can be obtained.Contain keywords for this news item: Asia, Oncology, Tokushima, rectal cancer, GastroenterologyAfter the news editors, the researchers concluded: 'The preoperative RT with S-1 in possible combination was well tolerated.